Shibani S Harite

Title: Shibani S Harite: Innovator in Cancer Treatment

Introduction

Shibani S Harite is a notable inventor based in Fremont, California, recognized for her contributions to the field of cancer treatment. With a total of three patents to her name, she has made significant strides in developing innovative therapeutic methods.

Latest Patents

Among her latest patents is a groundbreaking work titled "Compositions and methods for achieving sustained therapeutic drug concentrations in a subject." This patent provides compounds and methods aimed at achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo. Another significant patent is "Sustained Exposure to Active Metabolite with PEG-Irinotecan Methods for treating humans having brain cancer." This method involves administering a therapeutically effective amount of a pharmaceutical composition to humans with brain cancer, utilizing a non-continuous dosing regimen that comprises administering the composition no more frequently than once every seven days for at least two dosings.

Career Highlights

Shibani is currently employed at Nektar Therapeutics, where she continues to advance her research and development efforts in oncology. Her work is pivotal in enhancing the efficacy of cancer treatments, providing hope for patients battling this challenging disease.

Collaborations

Shibani collaborates with esteemed colleagues, including Michael A Eldon and Tamra L Barker, who contribute to her innovative projects and research initiatives.

Conclusion

Shibani S Harite's work exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her patents reflect a commitment to improving therapeutic outcomes for patients, showcasing her role as a leading inventor in this vital area of healthcare.